Hyperbaric oxygen as an adjuvant treatment for patients with COVID-19 severe hypoxaemia: a randomised controlled trial | Emergency Medicine Journal

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via RCEM

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via RCEM

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Original research

Hyperbaric oxygen as an adjuvant treatment for patients with COVID-19 severe hypoxaemia: a randomised controlled trial

Online download statistics by month:

Online download statistics by month: December 2021 to March 2024

	Abstract	Full	Pdf
Dec 2021	2009	2021	346
Jan 2022	2574	2597	494
Feb 2022	1148	1110	222
Mar 2022	873	866	210
Apr 2022	324	309	98
May 2022	356	380	104
Jun 2022	282	280	65
Jul 2022	333	300	59
Aug 2022	226	189	78
Sep 2022	200	189	75
Oct 2022	187	178	48
Nov 2022	149	139	59
Dec 2022	119	189	34
Jan 2023	174	161	63
Feb 2023	140	137	39
Mar 2023	198	195	46
Apr 2023	114	94	30
May 2023	93	88	27
Jun 2023	99	91	27
Jul 2023	97	95	44
Aug 2023	102	91	20
Sep 2023	111	107	23
Oct 2023	83	71	40
Nov 2023	140	113	28
Dec 2023	171	153	38
Jan 2024	174	124	177
Feb 2024	84	80	59
Mar 2024	80	70	97
Total	10640	10417	2650